131 related articles for article (PubMed ID: 35081723)
1. Hyper-expression and hypomethylation of TM4SF1 are associated with lymph node metastases in papillary thyroid carcinoma patients.
Wang K; Zheng J; Wu Z; Fang JG; Zhao JY; Yao JM; Dong JJ; Bai J; Liao L
Neoplasma; 2022 Mar; 69(2):341-351. PubMed ID: 35081723
[TBL] [Abstract][Full Text] [Related]
2. Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients.
Wang K; Li H; Zhao J; Yao J; Lu Y; Dong J; Bai J; Liao L
Front Cell Dev Biol; 2022; 10():1001954. PubMed ID: 36568979
[No Abstract] [Full Text] [Related]
3. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
4. Prediction Biomarkers Associated with Lymph Node Metastasis and Prognosis were Identified in Papillary Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Gan S; Ye R; Ha Y; Xiong Y; Li R; Di X; Zou Z; Sun Y; Zhang Z
Comb Chem High Throughput Screen; 2021; 24(9):1395-1409. PubMed ID: 33155892
[TBL] [Abstract][Full Text] [Related]
5. Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma.
Bohec H; Breuskin I; Hadoux J; Schlumberger M; Leboulleux S; Hartl DM
World J Surg; 2019 Mar; 43(3):818-823. PubMed ID: 30465086
[TBL] [Abstract][Full Text] [Related]
6. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
[TBL] [Abstract][Full Text] [Related]
7. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
Paulson L; Shindo M; Schuff K; Corless C
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
[TBL] [Abstract][Full Text] [Related]
8. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
10. Correlation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma.
Zhao F; Zhu S; Fang J; Dong H; Zhu C
Head Neck; 2023 Jul; 45(7):1654-1662. PubMed ID: 37097909
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases.
Yang J; Gong Y; Yan S; Zhu J; Li Z; Gong R
Cancer Med; 2016 Aug; 5(8):2161-8. PubMed ID: 27368106
[TBL] [Abstract][Full Text] [Related]
12. Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
Lu DN; Zhang WC; Lin YZ; Jiang HY; He R; Li SL; Zhang YN; Shao CY; Zheng CM; Xu JJ; Ge MH
J Endocrinol Invest; 2024 Jun; 47(6):1513-1530. PubMed ID: 38146045
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G
J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
Wu G; Zhou Y; Li T; Guo J; Zhou Z
J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors analyses for lateral neck lymph node metastasis in papillary thyroid carcinoma].
Qi ZJ; Liu LF; Cheng L; Han X; Wang T; Li F; Lu C; Zhang AB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):603-606. PubMed ID: 31327195
[No Abstract] [Full Text] [Related]
16. Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe.
Kim SY; Kim SM; Chang H; Kim BW; Lee YS; Chang HS; Park CS
ANZ J Surg; 2019 Nov; 89(11):E498-E501. PubMed ID: 31566299
[TBL] [Abstract][Full Text] [Related]
17. Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.
Zhang X; Chen W; Fang Q; Fan J; Feng L; Guo L; Liu S; Ge H; Du W
Front Endocrinol (Lausanne); 2021; 12():716082. PubMed ID: 34335480
[TBL] [Abstract][Full Text] [Related]
18. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
[TBL] [Abstract][Full Text] [Related]
19. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study.
Liu Y; Wang Y; Zhao K; Li D; Chen Z; Jiang R; Wang X; He X
BMC Cancer; 2020 Mar; 20(1):181. PubMed ID: 32131769
[TBL] [Abstract][Full Text] [Related]
20. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma.
Vergez S; Sarini J; Percodani J; Serrano E; Caron P
Eur J Surg Oncol; 2010 Aug; 36(8):777-82. PubMed ID: 20584589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
